England's NHS must offer transgender patients awaiting transitioning treatment access to fertility services, or face legal action according to the country's equality watchdog.
The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar and generic drugs, which are considered to be “equally effective alternatives
